In Vitro Efficacy of Antivenom and Varespladib in Neutralising Chinese Russell’s Viper (Daboia siamensis) Venom Toxicity
Open Access
Abstract
The venom of the Russell’s viper (Daboia siamensis) contains neurotoxic and myotoxic phospholipase A2 toxins which can cause irreversible damage to motor nerve terminals. Due to the time delay between envenoming and antivenom administration, antivenoms may have limited efficacy against some of these venom components. Hence, there is a need for adjunct treatments to circumvent these limitations. In this study, we examined the efficacy of Chinese D. siamensis antivenom alone, and in combination with a PLA2 inhibitor, Varespladib, in reversing the in vitro neuromuscular blockade in the chick biventer cervicis nerve-muscle preparation. Pre-synaptic neurotoxicity and myotoxicity were not reversed by the addition of Chinese D. siamensis antivenom 30 or 60 min after venom (10 µg/mL). The prior addition of Varespladib prevented the neurotoxic and myotoxic activity of venom (10 µg/mL) and was also able to prevent further reductions in neuromuscular block and muscle twitches when added 60 min after venom. The addition of the combination of Varespladib and antivenom 60 min after venom failed to produce further improvements than Varespladib alone. This demonstrates that the window of time in which antivenom remains effective is relatively short compared to Varespladib and small-molecule inhibitors may be effective in abrogating some activities of Chinese D. siamensis venom.Keywords
Funding Information
- Australian National Health and Medical Research Council (NHMRC) Senior Research Fellowship (1154503, 1110343, 202102010282, 2022A1515012095)
- NHMRC Centres for Research Excellence Grant (1154503, 1110343, 202102010282, 2022A1515012095)
- Guangzhou Science and Technology Program City and University (Hospital) joint funded Grant (1154503, 1110343, 202102010282, 2022A1515012095)
- Natural Science Foundation of Guangdong Basic and Applied Basic Research Foundation (1154503, 1110343, 202102010282, 2022A1515012095)
This publication has 58 references indexed in Scilit:
- Neurotoxicity in Snakebite—The Limits of Our KnowledgePLOS Neglected Tropical Diseases, 2013
- Structural and pharmacological comparison of daboiatoxin fromDaboia russelli siamensiswith viperotoxin F and vipoxin from other vipersActa Crystallographica Section D Structural Biology, 2007
- Differential susceptibility of C2C12 myoblasts and myotubes to group II phospholipase A2 myotoxins from crotalid snake venomsCell Biochemistry and Function, 2005
- Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicityToxicon, 2003
- Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymesToxicon, 2003
- Pharmacokinetic-Pharmacodynamic Relationships of Immunoglobulin Therapy for EnvenomationClinical Pharmacokinetics, 2003
- Two types of russell's viper revealed by variation in phospholipases A2 from venom of the subspeciesToxicon, 1996
- A major lethal factor of the venom of Burmese Russell's viper (Daboia russelli siamensis): Isolation, n-terminal sequencing and biological activities of daboiatoxinToxicon, 1995
- Characterization and molecular cloning of neurotoxic phospholipases A2 from Taiwan viper (Vipera russelli formosensis)European Journal of Biochemistry, 1992
- A model to explain the pharmacological effects of snake venom phospholipases A2Toxicon, 1989